September 9, 2020 – Tosoh Bioscience, Inc. (San Francisco, CA) has introduced the ST AIA-PACK BNP assay, designed for in vitro diagnostic use only for the quantitative measurement of BNP in human (K2EDTA) plasma on Tosoh AIA System Analyzers.
BNP is used as an aid in the diagnosis of heart failure (HF) in patients presenting to the emergency department (ED) with clinical suspicion of new onset HF, acutely decompensated or exacerbated HF.
Utilizing Tosoh’s unit dose test cup reagent technology, ST AIA-PACK BNP has an assay time of approximately 18 minutes. Single, unitized test cups require no pre-mixing, no pre-measuring and no on-board refrigeration. Dry reagent format ensures 90-day calibration stability for minimal waste and cost-effective testing. Test cups are barcoded for easy identification and inventory management.
The ST AIA-PACK BNP assay has an assay range of 4 to 2000 pg/mL and is free from Biotin interference.